TMS Therapy Success With Antidepressants: What Works
Table of Contents
How TMS Therapy Works Alongside Antidepressants
TMS vs. Antidepressants: Head-to-Head Outcomes
What the comparison actually measures
Response, partial response, and remission are not the same thing
How prior medication history changes the picture
Why "TMS beats medication" is the wrong takeaway
TMS Success Rate for Depression When Combined With Medication
What "success" means in combination treatment
Why combination treatment is common in practice
Medication management during TMS
What predicts a better combination outcome
The honest caveat
How Long Does TMS Take to Work With Antidepressants
Stopping Antidepressants During TMS: What the Evidence Shows
Who Benefits Most From Combining TMS and Medication
Safety, Side Effects, and Practical Considerations
Frequently Asked Questions
Last Updated: October 13, 2026
How TMS Therapy Works Alongside Antidepressants
TMS therapy success with antidepressants depends on how the two complement each other. TMS uses magnetic pulses to stimulate mood-regulating brain regions; antidepressants adjust neurotransmitter levels chemically, two distinct mechanisms at once.
At Newtown TMS, many patients continue their antidepressant during TMS. The magnetic stimulation targets the left dorsolateral prefrontal cortex, a region with reduced activity in major depressive disorder, while medication maintains baseline neurochemical support, often producing results neither achieves alone.
Timing is the key difference. Antidepressants typically need 4-6 weeks for noticeable effects; TMS can produce measurable improvement within 2-3 weeks for some patients. Together, patients sometimes see faster, more sustained relief.
Pro Tip If you've struggled with antidepressants in the past, combining them with TMS doesn't mean repeating a failed approach. TMS can work synergistically with medications that previously showed only partial benefit, sometimes unlocking better outcomes than either treatment delivered independently.
TMS vs. Antidepressants: Head-to-Head Outcomes
Most pages compare TMS and antidepressants like two products on a shelf. That framing breaks down: the treatments are rarely studied in the same patients, at the same time, with the same outcome measure.
What the comparison actually measures
When researchers compare TMS with antidepressants, they typically use one of three designs:
Placebo- or sham-controlled trials of TMS in patients who are already on medication. The comparison is TMS plus medication versus sham plus medication.
Medication-switch trials in which a patient who has not responded to one antidepressant is randomized to a new antidepressant or to an augmentation strategy.
Open-label or registry studies that follow real-world patients through whatever treatment they and their clinician choose. These reflect practice but cannot prove cause and effect.
These designs answer different questions. A sham-controlled trial shows whether TMS adds benefit beyond medication; a switch trial shows whether changing medication helps. Neither proves TMS is "better" in general.
Response, partial response, and remission are not the same thing
A recurring problem in popular coverage is that "success" is used loosely. In clinical research, three terms carry specific meanings:
Response usually means a meaningful reduction in symptom severity, commonly described as at least a 50% drop on a standardized depression rating scale such as the PHQ-9 or HAM-D.
Partial response means improvement that falls short of that threshold. The patient feels better but is not well.
Remission means symptoms have dropped below a defined cutoff, often a PHQ-9 score under 5 or a HAM-D score under 7, for a sustained period. Remission is the goal, because residual symptoms predict relapse.
A treatment can produce a high response rate and a lower remission rate. If a page quotes one number, ask which it is.
How prior medication history changes the picture
The single biggest predictor of how someone will do with TMS is how they have done with medication. A useful way to think about it:
No prior antidepressant trials. For mild-to-moderate depression in someone never treated, antidepressants remain a reasonable first step, widely available, no office visits, and effective for many.
One or two failed trials. This is where the comparison gets genuinely close. Guidelines generally support either another medication trial or a non-medication option such as TMS, depending on side-effect burden and patient preference.
Two or more failed trials (treatment-resistant depression). This is the population TMS was cleared for and where the evidence is strongest. Adding TMS to an existing regimen, or switching to TMS, tends to outperform yet another medication switch in this group.
Prior TMS exposure. Patients who responded before often respond again, though durability varies. Prior non-response does not rule out a second course, but it changes the conversation.
Why "TMS beats medication" is the wrong takeaway
Antidepressants offer no office visits, lower upfront cost, and decades of safety data. TMS offers no systemic drug side effects, no daily pill, and a mechanism independent of neurotransmitter response. For a never-treated patient, medication is usually first; after two or more failed adequate trials, the calculus flips.
The honest summary: the two treatments are sequential and complementary, not competitors. The right question isn't "which is better" but "given my treatment history, what is most likely to help next?"
Key Takeaway Head-to-head numbers are only meaningful when you know the population, the comparator, and the outcome definition. Response, partial response, and remission are different endpoints, and prior medication history changes which treatment is likely to help most.
TMS Success Rate for Depression When Combined With Medication
Combination outcomes depend on who you are, what you've tried, and how "success" is defined.
What "success" means in combination treatment
Before quoting any rate, define the endpoint:
Response rate, the share of patients whose symptom scores drop by roughly half. In TMS studies of treatment-resistant depression, response rates commonly fall in the range of 50-60% by the end of an acute course, though figures vary widely by study design and population (pubmed.ncbi.nlm.nih.gov).
Remission rate, the share who fall below the remission threshold. This is typically lower than the response rate, often in the 30-40% range in the same studies.
Durability, how many responders are still well at 3, 6, and 12 months. This is the number patients care about most and the one least often reported.
When a page says "TMS has a 60% success rate," ask which endpoint it means.
Why combination treatment is common in practice
Most patients entering a TMS course are already on an antidepressant, and discontinuing beforehand is not standard practice, for three reasons:
Safety. Abrupt antidepressant discontinuation can cause withdrawal symptoms and mood destabilization.
Interpretation. If you stop medication and start TMS at the same time, you cannot tell which change produced the effect.
Baseline stability. Keeping medication constant gives the brain a stable neurochemical environment while TMS introduces a new mechanism.
The result: most real-world TMS outcomes are combination outcomes, even in studies described as "TMS trials."
Medication management during TMS
A few medication-management principles are worth knowing:
Do not change medications on your own. Any adjustment, dose, timing, addition, or taper, should go through your prescriber.
Coordinate your providers. Your TMS clinic and your prescribing clinician should be in contact. At minimum, each should know what the other is doing and when changes are planned.
Avoid changes during the acute course unless medically necessary. A mid-course change muddies the picture and makes it harder to know whether TMS is working.
Plan any taper for after the acute course. If the goal is to reduce or stop medication after achieving remission, that conversation typically happens weeks to months after TMS ends, with a slow taper under supervision.
Watch for interactions and seizure risk. TMS carries a small seizure risk. Certain medications and substances, some stimulants, bupropion at higher doses, alcohol or illicit stimulants, can raise it. Your TMS provider should review your full medication list beforehand.
Watch Out Never stop or change an antidepressant on your own while starting TMS. Withdrawal symptoms and mood destabilization can undermine the treatment you are trying to benefit from. All medication changes should be coordinated between your prescriber and your TMS provider.
What predicts a better combination outcome
Across studies and clinical experience, a few factors consistently track with better results:
Fewer prior failed trials. Patients who have failed one or two antidepressants tend to do better than those who have failed five or more.
Consistent attendance. TMS requires roughly 20-30 sessions over 4-6 weeks. Missed sessions reduce cumulative dose and often reduce benefit.
Stable medication. A constant regimen during the acute course makes it easier to attribute improvement to TMS and avoids confounding.
Realistic expectations. Response often begins in the second or third week. Patients who expect immediate change may discontinue too early.
The honest caveat
Combination treatment is not a guarantee: some patients respond fully, some partially, some not at all. Its value is expanding the mechanisms engaged, chemical and electrical, rather than betting on one. For someone who has cycled through multiple antidepressants without relief, that expansion is often the difference between waiting and finally getting traction.

How Long Does TMS Take to Work With Antidepressants
The timeline for TMS therapy success with antidepressants differs from medication alone. Antidepressants typically need 4-6 weeks for meaningful improvement; TMS works faster for many patients.
Most TMS courses involve 20-30 sessions over 4-6 weeks, with patients continuing their antidepressants as prescribed. The combination often produces noticeable changes in mood, sleep, and motivation within 2-3 weeks; some report improvement sooner.
Pace varies by individual. Prior antidepressant response, the specific TMS protocol, and overall health influence how quickly results appear.
A practical advantage: you don't have to choose between waiting for medication and starting TMS.
Stopping Antidepressants During TMS: What the Evidence Shows
Patients often ask whether to stop their antidepressant during TMS. The short answer: most should not. Continuing medication maintains neurochemical stability while stimulation is introduced.
Stopping abruptly can trigger withdrawal symptoms and destabilize mood.
Some patients taper antidepressants after completing TMS, particularly after remission, but this requires medical oversight, discontinuing too quickly can cause relapse.
The evidence supports maintaining medication continuity during TMS. This combination approach has shown better outcomes than either treatment alone, especially for treatment-resistant depression. Your physician can determine the right strategy for you.
Watch Out Never stop taking antidepressants on your own while starting TMS. Abrupt discontinuation can cause withdrawal symptoms and mood destabilization. Any changes to your medication should be discussed with your prescribing physician and coordinated with your TMS provider.
Who Benefits Most From Combining TMS and Medication
Not everyone needs to combine TMS with antidepressants. The clearest candidates are people with treatment-resistant depression who've tried multiple medications without adequate relief.
Patients with intolerable antidepressant side effects also benefit: TMS can work synergistically with lower doses, sometimes allowing a dose reduction while maintaining symptom control, addressing both the depression and the medication burden.
Working professionals whose depression interferes with productivity often find combination treatment most valuable.
People with chronic, recurrent depression often see better long-term outcomes with combination therapy.
Safety, Side Effects, and Practical Considerations
Combining TMS therapy success with antidepressants requires attention to safety and side effects from both.
Antidepressants carry their own side effects: sexual dysfunction, weight changes, sleep disturbance, and emotional blunting are common.
The practical consideration is consistency. At Newtown TMS, we work closely with your other healthcare providers to keep your treatment plan integrated.
Insurance coverage varies widely: some plans cover TMS, others require prior authorization or specific criteria. Medication costs depend on your plan and the specific antidepressant.
Combining TMS therapy success with antidepressants offers hope for people whose depression hasn't responded to medication alone.
Frequently Asked Questions
Can you take antidepressants while receiving TMS therapy?
Yes. Most patients continue their current antidepressants during TMS treatment. In fact, research suggests that combining TMS therapy with antidepressant medication often produces better outcomes than either treatment alone. Your physician will monitor your medication regimen throughout your TMS course to ensure safety and optimize results. Stopping medication abruptly during TMS is generally not recommended without explicit medical guidance.
Does TMS work better with antidepressants than either treatment alone?
Clinical evidence indicates that combination treatment, TMS plus continuing antidepressants, can produce higher remission rates than TMS monotherapy or medication alone, particularly for treatment-resistant depression. Studies show that patients who have failed multiple antidepressants often respond better when TMS is added to their existing medication. However, individual outcomes vary based on treatment history, symptom severity, and other factors. A physician-led consultation can help determine the best approach for your specific situation.
How long does TMS take to work when combined with antidepressants?
Most patients begin noticing symptom improvement within 2-4 weeks of starting TMS treatment, though some see changes sooner. A typical TMS course spans 4-6 weeks with daily sessions. When combined with antidepressants, the timeline may vary depending on how long you've been on your current medication and your individual response pattern. Full therapeutic benefit often emerges over several weeks of consistent treatment. Your physician will track your progress throughout the course.
What should I expect if I've tried multiple antidepressants without success?
Treatment-resistant depression, defined as inadequate response to at least two antidepressant trials, affects a significant portion of patients with major depressive disorder. TMS therapy was specifically FDA-cleared for this population. Adding TMS to your current medication regimen offers a neuromodulation approach that works through a different mechanism than antidepressants, making it effective for many patients who have not responded to medication alone. A consultation with a TMS specialist can assess whether you're a candidate based on your treatment history.
Call Newtown TMS for a free consultation




Comments